ArticleEuropean heart journal2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Erratum issued 9 registry-linked trialsAbstract read
In one paragraph
Article in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 9 registered trials, which are not on this map. Cited by 1,827 papers, 9 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,827citing papers in PubMed, 9 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
PMID 30403574PMID 25773607PMID 28304224PMID 26039521PMID 36031810PMID 35508320PMID 24161333PMID 37416519PMID 31248666PMID 31887831PMID 29653628PMID 21543628other papers from this trial
Open the trial in the graphEffect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity: a Randomized Clinical Trial (SPIROTOX Trial)
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry (ISACS CARDIONCO-PREDICT)
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
To Investigate the Effect of Multidisciplinary Care Approach on Cardiovascular Risk Modification in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Exercise in Regional Breast Cancer With Neoadjuvant Anthracycline- Based Chemotherapy and Immunotherapy With Checkpoint-Inhibition
Rationale and Design of a Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab: A Randomized, Active Control Group, Open-Label Trial
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity - SPRINT
Prospective and Molecular Biomarker-Based Evaluation of Cardiac Side Effects in Patients With Early-Stage Breast Cancer Receiving Systemic Therapy: A Single-Center Observational Cohort Study
Who cites it
1,827 citing papers in PubMed, 9 syntheses or guidelines pooled it.
- Structured exercise and cardiac outcomes during anthracycline or anti-HER2 therapy in breast cancer: systematic review and meta-analysis of randomized trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Cardiovascular risk-prediction models in cancer survivors: a meta-analysis.European heart journal · 2026Pooled it
- Exercise for the mitigation of cancer therapy-related cardiac dysfunction in breast cancer patients treated with anthracyclines: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Prevalence of Cancer Across Cardiovascular and Cardiometabolic Conditions: A Systematic Review and Meta-Analysis.European journal of clinical investigation · 2026Pooled it
- Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.Open heart · 2026Pooled it
- Synthesis of clinical practice guidelines and recommendations for breast cancer survivorship care: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.Targeted oncology · 2026Pooled it
- Cardiotoxicity in pediatric oncology: a systematic review and meta-analysis.Pediatric research · 2026Pooled it
- Long-term cardiovascular risk in survivors of hematologic malignancies: a meta-analysis.BMC cancer · 2026Pooled it
- Association between comorbidity burden and subclinical cardiac dysfunction in cancer patients prior to chemotherapy.Hong Kong physiotherapy journal : official publication of the Hong Kong Physiotherapy Association Limited = Wu li chih liao · 2026Article
- Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study.Advances in radiation oncology · 2026Article
- Determining oncology nurses' awareness of cardio-oncology in Türkiye: A descriptive study.Asia-Pacific journal of oncology nursing · 2026Article
- Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma.Hepatic oncology · 2026Review
- Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial.Future science OA · 2026Article
- Mapping the global landscape of research on immune checkpoint inhibitor-associated cardiotoxicity: A quantitative and visualized bibliometric study (2016-2025).Human vaccines & immunotherapeutics · 2026Article
- Asymptomatic Cardiotoxicity After High-Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography.International journal of cancer · 2026Article
- Mutations in CHIP-associated genes at myeloid neoplasm diagnosis and risk of cardiovascular/cerebrovascular events.Annals of medicine · 2026Article
- The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact.Journal of immunotherapy and precision oncology · 2026Review
- Reversible osimertinib-associated heart failure mimicking cancer recurrence inExperimental and therapeutic medicine · 2026Article
- Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
1,767 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Erratum issued
Authors and funding
31 authors.
Alexander R Lyon(United Kingdom).
Teresa López-Fernández(Spain).
Liam S Couch(United Kingdom).
Riccardo Asteggiano(Italy).
Marianne C Aznar(United Kingdom).
Jutta Bergler-Klein(Austria).
Giuseppe Boriani(Italy).
Daniela Cardinale(Italy).
Raul Cordoba(Spain).
Bernard Cosyns(Belgium).
David J Cutter(United Kingdom).
Evandro de Azambuja(Belgium).
Rudolf A de Boer(Netherlands).
Susan F Dent(United States of America).
Dimitrios Farmakis(Cyprus).
Sofie A Gevaert(Belgium).
Diana A Gorog(United Kingdom).
Joerg Herrmann(United States of America).
Daniel Lenihan(United States of America).
Javid Moslehi(United States of America).
Brenda Moura(Portugal).
Sonja S Salinger(Serbia).
Richard Stephens(United Kingdom).
Thomas M Suter(Switzerland).
Sebastian Szmit(Poland).
Juan Tamargo(Spain).
Paaladinesh Thavendiranathan(Canada).
Carlo G Tocchetti(Italy).
Peter van der Meer(Netherlands).
Helena J H van der Pal(Netherlands).
ESC Scientific Document Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsHematologyNeoplasmsRadiation OncologyHeartHumansMedical OncologyAntineoplastic AgentsAmyloid light-chain cardiac amyloidosisAndrogen deprivation therapyAnthracyclineArrhythmiasAtrial fibrillationBiomarkersCancerCancer survivorsCarcinoid syndromeCardiac magnetic resonanceCardiac tumourCardio-oncologyCardiotoxicityChemotherapyCoronary artery diseaseEchocardiographyFluoropyrimidineGuidelinesHaematopoietic stem cell transplantationHeart failureHormone therapyHypertensionImmunotherapyIschaemic heart diseaseMyocarditisPericardial diseaseProteasome inhibitorsPulmonary hypertensionQTc prolongationRadiotherapyRisk stratificationStrainThrombosisTrastuzumabValvular heart diseaseVascular endothelial growth factor inhibitors (VEGFi)Venous thromboembolism
Identifiers
PMID
36017568What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT05976893ClinicalTrials.gov
NCT06005259ClinicalTrials.gov
NCT06086132ClinicalTrials.gov
NCT06130709ClinicalTrials.gov
NCT06163924ClinicalTrials.gov
NCT06672120ClinicalTrials.gov
and 3 more above
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.